[PDF] Top 20 Visibilidad internacional de las revistas españolas de historia
Has 10000 "Visibilidad internacional de las revistas españolas de historia" found on our website. Below are the top 20 most common "Visibilidad internacional de las revistas españolas de historia".
Reassessment: Vagus nerve stimulation for epilepsyA Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... high stimulation showed an average reduction in seizure frequency compared to baseline of 28%, versus 15% reduction in the 102 patients receiving low stimulation (p = ... See full document
6
Reassessment: Neuroimaging in the emergency patient presenting with seizure (an evidence-based review)Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... CT technology improves, multicenter studies, ideally including both imaging modalities, with a second set of blinded readers will be necessary to achieve adequate statistical power, particularly to investigate the ... See full document
6
EVALUATION OF SURGERY FOR PARKINSON’S DISEASE A Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... guidance. Stimulation through the electrode is used to find the site that produces the best suppression of tremor with the least paresthesias or other unwanted side ...lowest stimulation intensity with only ... See full document
16
Assessment: Efficacy of transcutaneous electric nerve stimulation in the treatment of pain in neurologic disorders (an evidence-based review)Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... This statement is provided as an educational service of the American Academy of Neurology. It is based on an assessment of current scientific and clinical information. It is not intended to ... See full document
8
Practice Advisory: Utility of surgical decompression for treatment of diabetic neuropathyReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... pressed nerves improved in their two-point discrimination test postoperatively. None of the decompressed nerves worsened, whereas 32% of the contralateral non-treated nerves worsened in their two-point discrimination (p ... See full document
13
Assessment: Prevention of post–lumbar puncture headachesReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... with Sprotte (noncutting) 21-G needles to one of two groups. In one group, the stylet was reinserted before withdrawal. In the other group, the stylet was not reinserted. PLPHA was reported in 16% of the patients in the ... See full document
23
Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): [RETIRED]Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... of BoNT to block acetylcholine release at neuro- muscular junctions accounts for its therapeutic action to relieve dystonia, spasticity, and related disorders. The toxin has additional therapeutic benefits, not ... See full document
8
Evidence-based guideline update: Vagus nerve stimulation for the treatment of epilepsyReport of the Guideline Development Subcommittee of the American Academy of Neurology
... “vagus nerve stimulation,” and “neurostimulation” (appendices ...s assessment of seizures ...an assessment of seizure frequency were deemed as meeting criteria for Class III evidence ... See full document
6
Clinical utility of surface EMGReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... SEMG is a technique to measure muscle activity noninvasively using surface electrodes placed on the skin overlying the muscle. SEMG differs from NEMG and FWEMG with respect to technical requirements and electrical ... See full document
9
Evidence-based guideline update: Plasmapheresis in neurologic disordersReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... receives technology royalties from Abbott, Johnson & Johnson, and sanofi-aventis; receives publishing royalties for Harrison’s Principles of In- ternal Medicine, 17th ...on nerve conduction studies; has ... See full document
27
Evidence-based guideline: Clinical evaluation and treatment of transverse myelitisReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... the American Academy of Neurology diagnostic (questions 1 and 2), prognostic (question 3), or thera- peutic (questions 4 and 5) classification of evidence schemes (appendix ... See full document
24
Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disordersReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... ⫽ American Academy of Neurology; AE ⫽ adverse effect; CI ⫽ confidence interval; CIDP ⫽ chronic inflammatory demyelinating polyneuropathy; FDA ⫽ Food and Drug Administration; GBS ⫽ Guillain-Barre ´ ... See full document
25
Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review)Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... DISCLAIMER This statement is provided as an educational service of the American Academy of Neurology. It is based on an assessment of current scientific and clinical information. It is not in- ... See full document
16
Assessment: Use of epidural steroid injections to treat radicular lumbosacral painReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... extent possible, the AAN keeps separate those who have a financial stake in the success or failure of the products appraised in the CPGs and the developers of the guidelines. Conflict of interest forms were ob- tained ... See full document
8
Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosisReport of the Guideline Development, Dissemination, and Implementation Subcommittee of the American Academy of Neurology
... The American Academy of Neurology is committed to pro- ducing independent, critical, and truthful clinical practice guidelines ...neurologists, Neurology peer reviewers, and representatives ... See full document
46
Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsyReport of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society
... evidence-based assessment provide guidelines for the prescription of AEDs for patients with refractory epilepsy and identify those seizure types and syndromes where more evidence is ... See full document
10
Naturalistic study of guideline implementation tool use via evaluation of website access and physician survey
... The AAN randomly selected 800 of its 855 eligible mem- bers to complete an online survey (Additional file 1) regarding use of the sports concussion guideline and its related GItools six months after it was launched in ... See full document
7
Efficacy and tolerability of the new antiepileptic drugs I: Treatment of new onset epilepsyReport of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society
... From the University of Pennsylvania (Dr. French), Philadelphia; Department of Neurological Sciences (Drs. Kanner and Bergen), Rush Medical College, Chicago, IL; The Cleveland Clinic Foundation (Dr. Bautista), OH; ... See full document
8
Assessment: The use of natalizumab (Tysabri) for the treatment of multiple sclerosis (an evidence-based review)Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... The clinical and radiologic impact of natalizumab (Tysabri) as therapy for multiple sclerosis (MS) is assessed. On the basis of Class I evidence, natalizumab has been demonstrated to reduce mea- sures of disease activity ... See full document
6
Neutralizing antibodies to interferon beta: Assessment of their clinical and radiographic impact: An evidence reportReport of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
... It is possible that NAbs attach to the receptor-binding region of the IFN  molecule, whereas non-NAbs attach to less critical epitopes. Some BAbs seem to have little measurable impact on IFN  activity (as it is ... See full document
8
Related subjects